RU95115628A - METHOD OF INTENSIVE THERAPY IN PATIENTS WITH TRAUMATIC SHOCK - Google Patents

METHOD OF INTENSIVE THERAPY IN PATIENTS WITH TRAUMATIC SHOCK

Info

Publication number
RU95115628A
RU95115628A RU95115628/14A RU95115628A RU95115628A RU 95115628 A RU95115628 A RU 95115628A RU 95115628/14 A RU95115628/14 A RU 95115628/14A RU 95115628 A RU95115628 A RU 95115628A RU 95115628 A RU95115628 A RU 95115628A
Authority
RU
Russia
Prior art keywords
traumatic shock
patients
hemodynamics
dose
total peripheral
Prior art date
Application number
RU95115628/14A
Other languages
Russian (ru)
Other versions
RU2122415C1 (en
Inventor
А.Б. Муллов
С.В. Васильев
В.Д. Слепушкин
Original Assignee
Новокузнецкий государственный институт усовершенствования врачей
Filing date
Publication date
Application filed by Новокузнецкий государственный институт усовершенствования врачей filed Critical Новокузнецкий государственный институт усовершенствования врачей
Priority to RU95115628A priority Critical patent/RU2122415C1/en
Priority claimed from RU95115628A external-priority patent/RU2122415C1/en
Publication of RU95115628A publication Critical patent/RU95115628A/en
Application granted granted Critical
Publication of RU2122415C1 publication Critical patent/RU2122415C1/en

Links

Claims (1)

Способ интенсивной терапии травматического шока, включающий обезболивание, инфузионную терапию, восполнение кровопотери, искусственную вентиляцию легких, медикаментозную коррекцию нарушений метаболизма, отличающийся тем, что на раннем госпитальном этапе у больных с травматическим шоком для стабилизации гемодинамики в зависимости от функционального состояния системы кровообращения вводят при наличии гипердинамического типа центральной гемодинамики - сердечный индекс ≥ 4,2 л • (мин • м2)- 1 и общее периферическое сопротивление сосудов ≤ 1200 дин • с • см- 5 - даларгин в дозе 1 мг внутривенно болюсно, а при наличии гиподинамического типа центральной гемодинамики - сердечный индекс ≤ 2,2 л • (мин • м2)- 1 и общее периферическое сопротивление сосудов > 2500 дин • с • см- 5 - актовегин в дозе 2000 мг в растворе 0,9%-ного натрия хлорида или 5%-ной глюкозы внутривенно инфузионно со скоростью 20 - 40 мл/мин.A method of intensive care for traumatic shock, including anesthesia, infusion therapy, replenishment of blood loss, mechanical ventilation, drug correction of metabolic disorders, characterized in that at an early hospital stage in patients with traumatic shock to stabilize hemodynamics, depending on the functional state of the circulatory system, is administered if hyperdynamic type of central hemodynamics - cardiac index ≥ 4.2 l • (min • m 2 ) - 1 and the total peripheral resistance of the vessel ov ≤ 1200 dyn • s • cm - 5 - dalargin at a dose of 1 mg is intravenously bolus, and in the presence of a hypodynamic type of central hemodynamics - cardiac index ≤ 2.2 l • (min • m 2 ) - 1 and the total peripheral vascular resistance> 2500 din • s • cm - 5 - actovegin at a dose of 2000 mg in a solution of 0.9% sodium chloride or 5% glucose by intravenous infusion at a rate of 20 - 40 ml / min.
RU95115628A 1995-09-05 1995-09-05 Method of intensive therapy of patients with traumatic shock RU2122415C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU95115628A RU2122415C1 (en) 1995-09-05 1995-09-05 Method of intensive therapy of patients with traumatic shock

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU95115628A RU2122415C1 (en) 1995-09-05 1995-09-05 Method of intensive therapy of patients with traumatic shock

Publications (2)

Publication Number Publication Date
RU95115628A true RU95115628A (en) 1997-09-10
RU2122415C1 RU2122415C1 (en) 1998-11-27

Family

ID=20171869

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95115628A RU2122415C1 (en) 1995-09-05 1995-09-05 Method of intensive therapy of patients with traumatic shock

Country Status (1)

Country Link
RU (1) RU2122415C1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2413528C2 (en) 2007-01-18 2011-03-10 Открытое Акционерное Общество "Валента Фармацевтика" Exenatide and dalargin drug for treating diabetes, adminisration and therapy
WO2021211006A1 (en) 2020-04-13 2021-10-21 Federal State Budgetary Institution Center Of Biomedical Technologies Of Federal Medical And Biological Agency Inhaled hexapeptide for treating interleukin-6 related respiratory diseases

Similar Documents

Publication Publication Date Title
Margulis et al. Temporary organ substitution by hemoperfusion through suspension of active donor hepatocytes in a total complex of intensive therapy in patients with acute hepatic insufficiency
Siegel et al. Association of sickle cell disease, priapism, exchange transfusion and neurological events: ASPEN syndrome
Gimson et al. Earlier charcoal haemoperfusion in fulminant hepatic failure
Taylor et al. Sodium nitroprusside as a hypotensive agent in general anaesthesia
Green et al. Death after acute withdrawal of intrathecal baclofen: case report and literature review
Palmer Effectiveness of hemodialysis in the extracorporeal therapy of phenobarbital overdose
Nilsson et al. Charcoal hemoperfusion for treatment of serious carbamazepine poisoning
Yang et al. Successful treatment of severe lactic acidosis caused by a suicide attempt with a metformin overdose
Vishnu et al. BRASH syndrome: a case report
RU95115628A (en) METHOD OF INTENSIVE THERAPY IN PATIENTS WITH TRAUMATIC SHOCK
Baker et al. Intraarterial infusion chemotherapy for head and neck cancer using a totally implantable infusion pump
Pomeranz et al. Acute renal failure in a burn patient: the advantages of continuous peritoneal dialysis
Van der Maten et al. Severe accidental hypothermia: rewarming with CVVHD
Mullins et al. Life-threatening diphenhydramine overdose treated with charcoal hemoperfusion and hemodialysis
Chan et al. Ammonia detoxification by continuous venovenous haemofiltration in an infant with urea cycle defect
CHASE Jr et al. Phenformin-associated pancreatitis
Ehgartner et al. Hemodynamic instability following intentional nadolol overdose
Milonovich et al. Charcoal hemoperfusion via a continous venovenous hemofiltration circuit to treat carbamazepine overdose
US5494900A (en) UDPG as a rescue agent in cancer therapy after the administration of antipyrimidine or related anti-tumor agents with or without BAU
Humphery Methanol poisoning: Management of acidosis with combined hemodialysis and peritoneal dialysis
SU1487909A1 (en) Method of detoxication of organism in post-surgery period
Kelly et al. Charcoal hemoperfusion treatment of severe theophylline toxicity
Wredling On the management of insulin-dependent diabetes mellitus.
Nzerue et al. Refractory hyperkalaemia associated with use of epsilon‐aminocaproic acid during coronary bypass in a dialysis patient
RU1811858C (en) Method of detoxification of organism